Tech Company Financing Transactions
SafeHeal Funding Round
SafeHeal, based in Paris, secured $10 million from Asabys Partners, Gideon Strategic Partners and M&L Healthcare.
Transaction Overview
Company Name
Announced On
9/11/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to further accelerate its pivotal U.S. IDE study and support the planned commercial launch of Colovac in the EU.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
40 Rue du Louvre
Paris, 75001
FR
Paris, 75001
FR
Phone
Website
Email Address
Overview
Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal's premier device, Colovac1, was designed to eliminate the need for diverting ostomy in patients undergoing colectomy. Clinical trials indicate that Colovac may improve and expedite recovery from colorectal surgery. This is an especially important benefit for surgeons, clinicians, and postoperative care professionals, and for the community of colorectal cancer patients worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Richardson
Browse more venture capital transactions:
Prev: 9/11/2025: Eloquent AI venture capital transaction
Next: 9/11/2025: OpenHealth Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs